Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

被引：0
|
作者：
Christine R Jenkins
Paul W Jones
Peter MA Calverley
Bartolome Celli
Julie A Anderson
Gary T Ferguson
Julie C Yates
Lisa R Willits
Jörgen Vestbo
机构：
[1] Woolcock Institute of Medical Research,Division of Cardiac and Vascular Science, St George's
[2] University of London,undefined
[3] University Hospital,undefined
[4] St Elizabeth's Medical Centre,undefined
[5] GlaxoSmithKline (GSK),undefined
[6] Pulmonary Research Institute of Southeast Michigan,undefined
[7] GSK,undefined
[8] Wythenshawe Hospital,undefined
[9] Hvidovre Hospital,undefined
来源：
Respiratory Research | / 10卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Fluticasone Propionate; Salmeterol; Severe Chronic Obstructive Pulmonary Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy of indacaterol as a single therapy versus salmeterol/fluticasone therapy in patients with milder chronic obstructive pulmonary disease
    Ruxandra, Ulmeanu
    Antoniu, Sabina Antonela
    Mihaltan, Florin
    Boisteanu, Daniela
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (10) : 1539 - 1541
  • [42] Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial
    Wouters, EFM
    Postma, DS
    Fokkens, B
    Hop, WCJ
    Prins, J
    Kuipers, AF
    Pasma, HR
    Hensing, CAJ
    Creutzberg, EC
    THORAX, 2005, 60 (06) : 480 - 487
  • [43] Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial
    Tashkin, DP
    Kanner, R
    Bailey, W
    Buist, S
    Anderson, P
    Nides, MA
    Gonzales, D
    Dozier, G
    Patel, MK
    Jamerson, BD
    LANCET, 2001, 357 (9268): : 1571 - 1575
  • [44] The efficacy and safety of fluticasone propionate 500 mg/salmeterol 50 mg combined via diskus®/accuhaler in Chinese patients with Chronic Obstructive Pulmonary Disease (COPD)
    Zheng, Jingping
    Zhong, Nanshari
    Yang, Lan
    Wu, Yarnei
    Chen, Ping
    Wen, Zhongguang
    Huang, Wenjie
    CHEST, 2006, 130 (04) : 182S - 182S
  • [45] Consistent Dosing Through the Salmeterol-Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime
    Turpeinen, Anni
    Eriksson, Patrik
    Happonen, Anita
    Husman-Piirainen, Johanna
    Haikarainen, Jussi
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (03) : 189 - 196
  • [46] Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease -: A double-blind, randomised, placebo-controlled, multicentre study
    Murphy, KR
    Eivindson, A
    Pauksens, K
    Stein, WJ
    Tellier, G
    Watts, R
    Léophonte, P
    Sharp, SJ
    Loeschel, E
    CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 337 - 349
  • [47] Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease
    Chatterjee, Arjun
    Shah, Manan
    D'Souza, Anna O.
    Bechtel, Benno
    Crater, Glenn
    Dalal, Anand A.
    RESPIRATORY RESEARCH, 2012, 13
  • [48] Evaluation of a therapeutic interchange from fluticasone/salmeterol to mometasone/formoterol in patients with chronic obstructive pulmonary disease
    Yip, Elaine
    Karimi, Sahar
    Pien, Linda
    PHARMACOTHERAPY, 2014, 34 (06): : E114 - E115
  • [49] Evaluation of a Therapeutic Interchange from Fluticasone/Salmeterol to Mometasone/Formoterol in Patients with Chronic Obstructive Pulmonary Disease
    Yip, Elaine
    Karimi, Sahar
    Pien, Linda T.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (04): : 316 - 323
  • [50] Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease
    Arjun Chatterjee
    Manan Shah
    Anna O D'Souza
    Benno Bechtel
    Glenn Crater
    Anand A Dalal
    Respiratory Research, 13
12345